<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-49-551C114">
 <label>114</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Kalogeropulou</surname>, 
    <given-names>A.F.</given-names>
   </string-name>, 
   <string-name>
    <surname>Zhao</surname>, 
    <given-names>J.</given-names>
   </string-name>, 
   <string-name>
    <surname>Bolliger</surname>, 
    <given-names>M.F.</given-names>
   </string-name>, 
   <string-name>
    <surname>Memou</surname>, 
    <given-names>A.</given-names>
   </string-name>, 
   <string-name>
    <surname>Narasimha</surname>, 
    <given-names>S.</given-names>
   </string-name>, 
   <string-name>
    <surname>Molitor</surname>, 
    <given-names>T.P.</given-names>
   </string-name>
   <etal>et al.</etal>
  </person-group> (
  <year>2018</year>) 
  <article-title>P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity</article-title>. 
  <source>Biochem. J.</source>
  <volume>475</volume>, 
  <fpage>1271</fpage>â€“
  <lpage>1293</lpage>
  <pub-id pub-id-type="doi">10.1042/BCJ20170699</pub-id>
  <pub-id pub-id-type="pmid">29519959</pub-id>
 </mixed-citation>
</ref>
